Devyn Smith, PhD, Arbor Biotechnologies, Cambridge, MA, shares his highlights from the “The past, present & future of gene delivery” session at Meeting on the Mesa 2021. Multiple approaches in delivering gene therapies have been successfully developed, including nanoparticles and adeno-associated virus (AAV) vectors, which will enable delivery of therapeutic products into new areas of the body. Dr Smith additionally focuses on the contents of these delivery systems, and how these treatments aim to permanently cure patients. This interview took place at Meeting on the Mesa 2021.